Highly glycosylated CD147 promotes hemorrhagic transformation after rt-PA treatment in diabetes: a novel therapeutic target?

Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke

(2017) Masato Kanazawa et al.   Journal of Atherosclerosis and Thrombosis

Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low‐Density Lipoprotein‐Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population‐Based Retrospective Cohort Study

(2017) Eric Yuk Fai Wan et al.   Journal of the American Heart Association

Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy

(2016) Ahmed M. Abu El-Asrar et al.   ACTA OPHTHALMOLOGICA

The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia

(2016) Fangzhe Chen et al.   Journal of Neuroinflammation

Omega-3 polyunsaturated fatty acids mitigate blood–brain barrier disruption after hypoxic–ischemic brain injury

(2016) Wenting Zhang et al.   NEUROBIOLOGY OF DISEASE

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix

(2015) Emma Robinson et al.   BASIC RESEARCH IN CARDIOLOGY

EMMPRIN, an upstream regulator of MMPs, in CNS biology

(2015) Deepak Kumar Kaushik et al.   MATRIX BIOLOGY

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke

(2015) Bart M. Demaerschalk et al.   STROKE

Amelioration of Ischemic Mitochondrial Injury and Bax-Dependent Outer Membrane Permeabilization by Mdivi-1

(2014) Yan-Xin Zhao et al.   CNS Neuroscience & Therapeutics

Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase

(2014) Kamini Rakkar et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Importance of N-Glycosylation on CD147 for Its Biological Functions

(2014) Yang Bai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner

(2014) Mei Cui et al.   MOLECULAR NEUROBIOLOGY

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes

(2013) Aisha I. Kelly-Cobbs et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium

(2013) Hiroshi Yamada et al.   BIOCHEMICAL PHARMACOLOGY

Gender Differences in 1-Year Clinical Characteristics and Outcomes after Stroke: Results from the China National Stroke Registry

(2013) Zhan Wang et al.   PLoS One

Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice

(2012) Lixiang Wang et al.   ANNALS OF NEUROLOGY

Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation

(2012) Wan Huang et al.   BIOCHEMICAL JOURNAL

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

(2012)   LANCET

Early Insulin Glycemic Control Combined With tPA Thrombolysis Reduces Acute Brain Tissue Damages in a Focal Embolic Stroke Model of Diabetic Rats

(2012) Xiang Fan et al.   STROKE

A Rat Model of Studying Tissue-Type Plasminogen Activator Thrombolysis in Ischemic Stroke With Diabetes

(2011) Xiang Fan et al.   STROKE

Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications

(2010) W. Bao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling

(2010) Mostafa M Elgebaly et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke

(2010) Jacek Kurzepa et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Molecular insights and therapeutic targets for blood–brain barrier disruption in ischemic stroke: Critical role of matrix metalloproteinases and tissue-type plasminogen activator

(2010) Rong Jin et al.   NEUROBIOLOGY OF DISEASE

Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients

(2009) Zi-Ming Du et al.   INTERNATIONAL JOURNAL OF CANCER

MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke

(2008) Anna Rosell et al.   STROKE